Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly
NCT04821674Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) (10 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Number of Participants Reporting Treatment-emergent Adverse Events, Number of Participants Reporting Local and Systemic Adverse Events and 4 more. Started Mar 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04821674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821674.